This is LondonEU Probe Finds Problems In Pharma Patent DealsWall Street JournalBRUSSELS (Dow Jones)--Big pharmaceutical companies will come under intensified antitrust scrutiny when making deals with smaller generic drug makers, the European Commission said Wednesday. ...EU targets drugmakers in generics antitrust probeReutersEU puts drugmakers on notice over medicine patentsUSA TodayTeva, Servier Face EU Antitrust Probe for Drug DelaysBloombergNew York Times -FiercePharma -This is Londonall 99 news articles »